Shaky data from European studies suggest that the long-acting insulin product Lantus might slightly increase cancer risk in people with type 2 diabetes. People should not stop taking Lantus because of this finding, says the FDA. A wide range of diabetes organizations -- and the editors of the journal that published the new findings -- agree that there's no cause for alarm.
"Do not stop taking your insulin. There is no immediate danger if you currently use or previously used [Lantus]," says the American Diabetes Association...read more
Saturday, 4 July 2009
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment